Monday, October 26, 2026
Via News Knowledge File

Adobe Inc.

organization80% conf.·synced Aug 13, 2026

Software company specializing in digital media, digital experience, and AI-powered creative tools

53
sourced metrics
481
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Price 52 Week Low
193.41USD
Aug 12, 2026reference only
Stock Price
258.75USD
Aug 12, 2026reference only
Stock Return Ytd
-22.4%
Aug 12, 2026reference only
Market Cap
106863750000USD
Aug 12, 2026reference only
Price 52 Week High
367.46USD
Aug 12, 2026reference only
Net Income
7.2USD
Jun 30, 2026source
Margin
2.24USD
Jun 11, 2026source
Backlog
27.10USD
Jun 11, 2026source
Cash
2.17USD
Jun 11, 2026source
Eps
4.25USD
Jun 11, 2026source
Free Cash Flow
10.26USD
Apr 1, 2026source
Intrinsic Value Per Share
531.44USD
Apr 1, 2026source
Pe Ratio
15ratio
Apr 1, 2026source
Valuation Score
5out_of_6
Apr 1, 2026source
Enterprise Value
97.1USD
Mar 28, 2026source
Ytd Stock Performance
-37percent
Mar 28, 2026source
Analyst Avg Price Target
328.19USD
Mar 28, 2026source
Forward Pe Ratio
10.0ratio
Mar 28, 2026source

Stated objectives

FY2026 Total Adobe ending ARR growth target

source
target: 10.2% year over year by 2026-11-30 00:00:00stated

Q1 FY2026 revenue guidance

source
target: $6.25-6.3B stated

Q1 FY2026 Business Professional/Consumer subscription revenue

source
target: $1.74-1.76B stated

Q1 FY2026 Creative/Marketing Professional subscription revenue

source
target: $4.3-4.33B stated

Q1 FY2026 non-GAAP operating margin

source
target: ~47% stated

FY2026 total revenue target

source
target: 25.90 to 26.10 billion USD by 2026-11-30 00:00:00stated

FY2026 total Adobe ARR book growth

source
target: 10.2% (~$2.6B net new ARR) stated

FY2026 Business Professionals/Consumer subscription revenue

source
target: $7.35-7.4B stated

FY2026 Creative/Marketing Professional subscription revenue

source
target: $17.75-17.9B stated

FY2026 non-GAAP operating margin

source
target: ~45% stated

Relationship graph · 481 connections

Developed by
163
Covered by
69
Competes with
52
Partners with
51
Customer of
49
Employs
37
acquired by
14
subsidiary of
7

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com